VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
N-Desethyl Sunitinib
CAS:356068-97-8
N-Desethyl Sunitinib (SU-11662) is a sunitinib metabolite.
Formula:
C20H23FN4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
370.42
Ref: TM-T12145
| 2mg | 85.00 € | ||
| 1mL*10mM (DMSO) | 149.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025
Toceranib
CAS:356068-94-5
Toceranib phosphate, orally active, inhibits RTK, PDGFR, VEGFR, Kit; Kis 5 nM PDGFRβ, 6 nM …
Formula:
C22H25FN4O2
Purity:
97.14%
Color and Shape:
Solid
Molecular weight:
396.46
Ref: TM-T13178
| 10mg | 47.00 € | ||
| 25mg | 65.00 € | ||
| 50mg | 88.00 € | ||
| 100mg | 116.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025
Su1498
CAS:168835-82-3
Su1498 (Tyrphostin SU 1498) is a selective inhibitor of the VEGF receptor 2, having negligible …
Formula:
C25H30N2O2
Purity:
99.54%
Color and Shape:
Solid
Molecular weight:
390.52
Ref: TM-T3980
| 1mg | 40.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 221.00 € | ||
| 50mg | 329.00 € | ||
| 100mg | 487.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Regorafenib Hydrochloride
CAS:835621-07-3
Regorafenib HCl (BAY73-4506) is an oral inhibitor targeting angiogenic, stromal, and cancer kinases with strong …
Formula:
C21H16Cl2F4N4O3
Purity:
100%
Color and Shape:
Solid
Molecular weight:
519.28
Ref: TM-T8402
| 5mg | 35.00 € | ||
| 10mg | 51.00 € | ||
| 25mg | 80.00 € | ||
| 50mg | 96.00 € | ||
| 100mg | 144.00 € | ||
| 500mg | 350.00 € | ||
| 1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Tesevatinib
CAS:781613-23-8
Tesevatinib (XL-647) is an oral, multi-targeted tyrosine kinase inhibitor.Cost-effective and quality-assured.
Formula:
C24H25Cl2FN4O2
Purity:
97.89% - 97.89%
Color and Shape:
Solid
Molecular weight:
491.39
Ref: TM-TQ0166
| 1mg | 107.00 € | ||
| 2mg | 156.00 € | ||
| 5mg | 236.00 € | ||
| 10mg | 457.00 € | ||
| 25mg | 750.00 € | ||
| 50mg | 1,026.00 € | ||
| 1mL*10mM (DMSO) | 255.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
NVP-ACC789
CAS:300842-64-2
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF …
Formula:
C21H17BrN4
Purity:
99.44% - 99.63%
Color and Shape:
Solid
Molecular weight:
405.29
Ref: TM-T3463
| 10mg | 46.00 € | ||
| 25mg | 58.00 € | ||
| 50mg | 92.00 € | ||
| 100mg | 150.00 € | ||
| 1mL*10mM (DMSO) | 34.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Alectinib
CAS:1256580-46-7
Alectinib (RG-7853) is an ALK inhibitor that is selective, orally active, and ATP-competitive. Alectinib has …
Formula:
C30H34N4O2
Purity:
98% - 99.97%
Color and Shape:
Solid
Molecular weight:
482.62
Ref: TM-T1936
| 2mg | 47.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 87.00 € | ||
| 50mg | 105.00 € | ||
| 100mg | 168.00 € | ||
| 200mg | 259.00 € | ||
| 500mg | 437.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
BMS-2
CAS:888719-03-7
BMS-2 is a Met/Flt-3/VEGFR2 tyrosine kinase inhibitor.
Formula:
C25H16F2N4O3
Purity:
98.33%
Color and Shape:
Solid
Molecular weight:
458.42
Ref: TM-T8326
| 1mg | 71.00 € | ||
| 2mg | 94.00 € | ||
| 5mg | 157.00 € | ||
| 10mg | 243.00 € | ||
| 25mg | 454.00 € | ||
| 50mg | 655.00 € | ||
| 100mg | 948.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
CZC-8004
CAS:916603-07-1
CZC-8004 (CZC-00008004) is a pan-kinase(ABL kinase) inhibitor and binds a range of tyrosine kinases.
Formula:
C17H16FN5
Purity:
99.29%
Color and Shape:
Solid
Molecular weight:
309.34
Ref: TM-T7186
| 1mg | 48.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 144.00 € | ||
| 25mg | 298.00 € | ||
| 50mg | 444.00 € | ||
| 100mg | 640.00 € | ||
| 1mL*10mM (DMSO) | 97.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Barlerin
CAS:57420-46-9
Barlerin (8-O-Acetylshanzhiside methyl ester) has potential against cerebral ischemic injury, and protective effect on oxygen-glucose …
Formula:
C19H28O12
Purity:
99.83% - ≥95%
Color and Shape:
Solid
Molecular weight:
448.42
Ref: TM-T5S1632
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 85.00 € | ||
| 10mg | 115.00 € | ||
| 25mg | 245.00 € | ||
| 50mg | 354.00 € | ||
| 100mg | 533.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Nintedanib
CAS:656247-17-5
Nintedanib (Intedanib) is a triple vascular kinase inhibitor that inhibits VEGFR1, VEGFR2, and VEGFR3 (IC50=34/13/13 …
Formula:
C31H33N5O4
Purity:
98% - 99.92%
Color and Shape:
Solid
Molecular weight:
539.62
Ref: TM-T1777
| 5mg | 46.00 € | ||
| 10mg | 59.00 € | ||
| 50mg | 70.00 € | ||
| 100mg | 92.00 € | ||
| 200mg | 141.00 € | ||
| 1mL*10mM (DMSO) | 55.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Mollugin
CAS:55481-88-4
Mollugin could be a JAK2 inhibitor, anti-inflammatory, chemotherapeutic agent in OSCCs, bone disorder therapy, and …
Formula:
C17H16O4
Purity:
98.31% - ≥95%
Color and Shape:
Solid
Molecular weight:
284.31
Ref: TM-T3673
| 5mg | 47.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 126.00 € | ||
| 50mg | 188.00 € | ||
| 100mg | 283.00 € | ||
| 500mg | 697.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Cabozantinib hydrochloride
CAS:1817759-42-4
Cabozantinib hydrochloride (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, …
Formula:
C28H25ClFN3O5
Purity:
97.09%
Color and Shape:
Solid
Molecular weight:
537.96
Ref: TM-T5164
| 1mg | 44.00 € | ||
| 2mg | 55.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 97.00 € | ||
| 25mg | 169.00 € | ||
| 50mg | 248.00 € | ||
| 100mg | 349.00 € | ||
| 200mg | 568.00 € | ||
| 500mg | 908.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
(Z)-Semaxinib
CAS:194413-58-6
(Z)-Semaxinib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor (IC50: 1.23 μM), 20-fold more selective …
Formula:
C15H14N2O
Purity:
96.09% - ≥95%
Color and Shape:
Solid
Molecular weight:
238.28
Ref: TM-T2496
| 1mg | 57.00 € | ||
| 5mg | 111.00 € | ||
| 10mg | 188.00 € | ||
| 25mg | 331.00 € | ||
| 50mg | 568.00 € | ||
| 100mg | 695.00 € | ||
| 200mg | 948.00 € | ||
| 1mL*10mM (DMSO) | 144.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
JK-P3
CAS:942655-44-9
JK-P3: a pyrazole inhibitor of VEGFR-2 (IC50: 7.8 μM), stalls FGFR 1/3 in vitro, halts …
Formula:
C18H17N3O3
Purity:
99.57%
Color and Shape:
Solid
Molecular weight:
323.35
Ref: TM-T4425
| 5mg | 39.00 € | ||
| 10mg | 65.00 € | ||
| 25mg | 131.00 € | ||
| 50mg | 226.00 € | ||
| 100mg | 335.00 € | ||
| 200mg | 469.00 € | ||
| 1mL*10mM (DMSO) | 44.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Dovitinib
CAS:405169-16-6
Dovitinib is an orally active, multi-targeted tyrosine kinase (RTK) inhibitor with anti-tumor effects.Cost-effective and quality-assured.
Formula:
C21H21FN6O
Purity:
99.66% - 99.78%
Color and Shape:
Solid
Molecular weight:
392.43
Ref: TM-T6289
| 5mg | 47.00 € | ||
| 10mg | 70.00 € | ||
| 25mg | 126.00 € | ||
| 50mg | 202.00 € | ||
| 100mg | 328.00 € | ||
| 200mg | 490.00 € | ||
| 500mg | 783.00 € | ||
| 1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
ODM-203
CAS:1430723-35-5
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor …
Formula:
C26H21F2N5O2S
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
505.54
Ref: TM-T7611
| 2mg | 43.00 € | ||
| 5mg | 65.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 202.00 € | ||
| 50mg | 349.00 € | ||
| 100mg | 518.00 € | ||
| 1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
Sitravatinib
CAS:1123837-84-2
Sitravatinib (MGCD516) (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, …
Formula:
C33H29F2N5O4S
Purity:
98.9% - 99.74%
Color and Shape:
Solid
Molecular weight:
629.68
Ref: TM-T4349
| 5mg | 51.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 137.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 338.00 € | ||
| 200mg | 535.00 € | ||
| 500mg | 845.00 € | ||
| 1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
4SC-203
CAS:895533-09-2
4SC-203 is a multi-kinase inhibitor with potential anti-tumor activity.Cost-effective and quality-assured.
Formula:
C33H38N8O4S
Purity:
96.4% - 99.73%
Color and Shape:
Solid
Molecular weight:
642.77
Ref: TM-T9473
| 1mg | 74.00 € | ||
| 5mg | 160.00 € | ||
| 10mg | 250.00 € | ||
| 25mg | 439.00 € | ||
| 50mg | 620.00 € | ||
| 100mg | 882.00 € | ||
| 1mL*10mM (DMSO) | 215.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
hVEGF-IN-1
CAS:1637443-98-1
hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
Formula:
C34H43N7O2
Purity:
100% - 98.85%
Color and Shape:
Solid
Molecular weight:
581.75
Ref: TM-T4288
| 1mg | 64.00 € | ||
| 5mg | 131.00 € | ||
| 10mg | 178.00 € | ||
| 25mg | 301.00 € | ||
| 50mg | 437.00 € | ||
| 100mg | 610.00 € | ||
| 200mg | 823.00 € |
Estimated delivery in United States, on Thursday 3 Apr 2025
